Ignite Creation Date:
2024-05-06 @ 1:04 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03920072
Status:
COMPLETED
Last Update Posted:
2022-05-20
First Post:
2018-10-29
Brief Title:
Study of the Anti-FGF23 Antibody Burosumab in Adults With XLH
Sponsor:
Kyowa Kirin Pharmaceutical Development Ltd
Organization:
Kyowa Kirin Pharmaceutical Development Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-29
First Submit QC Date:
April 17 2019
Study First Post Date:
2019-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-19
Last Update Post Date:
2022-05-20
Last Update Post Date Type:
ACTUAL